Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review

Archives of Hepatitis Research
Review Article
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of this disease ranges from steatosis to hepatitis and fi nally cirrhosis and hepatocellular carcinoma. 

https://www.peertechz.com/articles/farnesoid-x-receptor-agonist-as-a-new-treatment-option-for-non-alcoholic-fatty-liver-disease-a-review.pdf
 
 

Comments

Popular posts from this blog

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Case Report: Reynolds Syndrome

Ministernotomy Thymectomy in Mysthania Gravis-Future